Profound Medical (PROF) Return on Assets (2025 - 2026)

Profound Medical's (PROF) quarterly Return on Assets came in at 0.01% in Q1 2026, down 1.0% year-on-year from 0.01% in Q1 2025, and up 27.48% quarter-over-quarter from 0.01% in Q4 2025.

Profound Medical (PROF) Return on Assets (2025 - 2026) Analysis & Trends

Profound Medical's Return on Assets history runs 2 years deep, the most recent figure standing at 0.01% for Q1 2026.

  • On a quarterly basis, Return on Assets fell 1.0% year-over-year to 0.01% in Q1 2026; TTM through Mar 2026 was 0.01%, a 1.0% decrease from a year earlier, with the FY2025 full-year figure at 0.01%, down 1.0% from the prior year.
  • Return on Assets rose to 0.01% in Q1 2026 per PROF's latest filing, from 0.01% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.0% in Q1 2025 and bottomed at 0.01% in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 0.00%
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 0.00%
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 0.00%
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 0.00%
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 0.00%
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 0.00%
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 0.00%
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 0.00%
9 Smith & Nephew 25.80 Bn 25.22 Bn - 0.00%
10 Profound Medical 248.64 Mn 198.34 Mn 3.83 Mn -0.01%

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.01%
Dec 31, 2025 -0.01%
Sep 30, 2025 0.00%
Jun 30, 2025 0.00%
Mar 31, 2025 0.00%